4//SEC Filing
Bellon Steven F. 4
Accession 0001562180-24-000606
CIK 0001822462other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:02 PM ET
Size
5.6 KB
Accession
0001562180-24-000606
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-24$3.06/sh+110,000$336,600→ 110,000 totalExercise: $3.06Exp: 2034-01-23→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831749
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:02 PM ET
- Size
- 5.6 KB